News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,293 Results
Type
Article (88809)
Company Profile (816)
Press Release (794645)
Multimedia
Podcasts (239)
Webinars (35)
Section
Business (233604)
Career Advice (4163)
Deals (39993)
Drug Delivery (177)
Drug Development (91723)
Employer Resources (207)
FDA (18558)
Job Trends (17490)
News (398762)
Policy (40015)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (41)
Allergies (207)
Alliances (56990)
ALS (237)
Alzheimer's disease (1976)
Antibody-drug conjugate (ADC) (558)
Approvals (18910)
Artificial intelligence (881)
ASCO (345)
Autoimmune disease (363)
Automation (65)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (840)
Cancer (6626)
Cardiovascular disease (560)
Career advice (3599)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1077)
Cervical cancer (55)
Clinical research (79105)
Collaboration (2390)
Commercialization (1)
Company closure (8)
Compensation (1529)
Complete response letters (106)
COVID-19 (3043)
CRISPR (125)
C-suite (1298)
Cystic fibrosis (167)
Data (8782)
Decentralized trials (3)
Denatured (91)
Depression (197)
Dermatology (97)
Diabetes (713)
Diagnostics (7608)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (433)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102501)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138752)
Executive appointments (1199)
FDA (22660)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1959)
Gene editing (273)
Generative AI (90)
Gene therapy (856)
GLP-1 (1288)
Government (5562)
Grass and pollen (8)
Guidances (420)
Healthcare (21266)
Hematology (198)
HIV (97)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (355)
Immuno-oncology (116)
Indications (211)
Infectious disease (3444)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (150)
Intellectual property (324)
Interviews (822)
IPO (18006)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (123)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (876)
Lymphoma (480)
Machine learning (68)
Management (66)
Manufacturing (1241)
Marketing (1)
MASH (227)
Medical affairs (1)
Medical device (15285)
Medtech (15452)
Mergers & acquisitions (23304)
Metabolic disorders (1840)
mRNA (271)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (512)
Neuropsychiatric disorders (130)
Neuroscience (3742)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (82)
Obesity (875)
Opinion (375)
Ovarian cancer (245)
Pain (286)
Pancreatic cancer (359)
Parkinson's disease (420)
Partnered (40)
Patents (662)
Patient recruitment (770)
Peanut (71)
People (68037)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24451)
Phase 2 (34368)
Phase 3 (25833)
Pipeline (9898)
Policy (399)
Postmarket research (3560)
Preclinical (10991)
Press Release (72)
Prostate cancer (352)
Psychedelics (71)
Radiopharmaceuticals (374)
Rare diseases (1276)
Real estate (7462)
Recruiting (81)
Regulatory (30439)
Reports (77)
Research institute (2772)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (99)
Schizophrenia (197)
Series A (331)
Series B (240)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (148)
Tariffs (104)
The Weekly (145)
Vaccines (1313)
Venture capital (135)
Weight loss (600)
Women's health (142)
Worklife (24)
Date
Today (111)
Last 7 days (558)
Last 30 days (2984)
Last 365 days (33246)
2026 (16656)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (406)
Arkansas (16)
Asia (52327)
Australia (9197)
California (14455)
Canada (4031)
China (1587)
Colorado (622)
Connecticut (644)
Delaware (448)
Europe (120684)
Florida (2152)
Georgia (469)
Hawaii (4)
Idaho (70)
Illinois (1260)
India (105)
Indiana (667)
Iowa (26)
Japan (603)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1752)
Massachusetts (10585)
Michigan (426)
Minnesota (806)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3831)
New Mexico (35)
New York (3802)
North Carolina (1945)
North Dakota (11)
Northern California (7191)
Ohio (451)
Oklahoma (27)
Oregon (55)
Pennsylvania (2842)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5674)
Tennessee (232)
Texas (2356)
United States (51739)
Utah (430)
Vermont (1)
Virginia (372)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,293 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
Biopharmas that announced Series B financing this year and are looking for employees as they grow include two companies that received $100 million or more. One has partnerships with three Big Pharmas.
June 18, 2026
·
4 min read
·
Angela Gabriel
Job Trends
On the chopping block? When layoffs may and may not lurk around the corner
Cost cutting is just one factor driving biopharmas to whittle away at their workforces. An analyst discusses more common reasons layoffs occur and which employees are most at risk.
June 18, 2026
·
3 min read
·
Angela Gabriel
Job Trends
7 companies hiring in Boston
Looking for a job in Boston? Here’s a list of 7 companies on
BioSpace
currently hiring biopharma roles in Boston–plus a few more hiring in Waltham and Weston.
June 18, 2026
·
1 min read
·
Chantal Dresner
Press Releases
AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech’s Zabopegdutide in Phase 2 MASH Trial
June 18, 2026
·
5 min read
Press Releases
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody
June 18, 2026
·
3 min read
Press Releases
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
June 18, 2026
·
7 min read
Press Releases
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
June 18, 2026
·
2 min read
Press Releases
WuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
June 18, 2026
·
4 min read
Press Releases
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
June 18, 2026
·
11 min read
Press Releases
F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis
June 18, 2026
·
9 min read
1 of 88,430
Next
